Zantac not a cause of woman’s cancer, jury says in first trial over drug

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

The jury in Cook County, Illinois circuit court agreed with arguments from drugmakers GSK and Boehringer Ingelheim that the plaintiff, 89-year-old Illinois resident Angela Valadez, had not proven her colon cancer was at least in part caused by her Zantac use.

Valadez had alleged that her cancer was a result of taking over-the-counter Zantac and generic versions of it from 1995 to 2014.

The lawsuits over the drug say its active ingredient, ranitidine, under some conditions, turns into a cancer-causing substance called NDMA.

Attorneys for Valadez had asked the jury to award $640 million for her suffering. The judge rejected Valadez’s request to seek punitive damages during the trial, according to her attorneys.

Source: BBC

In other news – Big Zulu to host celebrity game 2024 in Durban

Hosting a celebrity game in Durban sounds like an exciting event! It’s a great opportunity for fans to see their favorite celebrities outside of their usual roles and engage in some friendly competition.

Events like these often bring communities together and create memorable experiences for both participants and spectators. Read more